Lv6
1790 积分 2023-05-04 加入
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
19小时前
待确认
The U.S. Food and Drug Administration’s Perspective on Chimeric Antigen Receptor T-Cell Therapies for Autoimmune and Rheumatic Conditions
17天前
已完结
Impact of corticosteroids on the efficacy of CD19/22 CAR-T cell therapy in pediatric patients with B-ALL: a single-center study
1个月前
已完结
In-vivo B-cell maturation antigen CAR T-cell therapy for relapsed or refractory multiple myeloma
2个月前
已完结
Inmunoterapia en el mieloma múltiple
2个月前
已完结
Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee
2个月前
已完结
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
2个月前
已完结
The hallmarks of cancer immune evasion
5个月前
已完结
Unravelling the genetics and epigenetics of the ageing tumour microenvironment in cancer
5个月前
已完结
Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapy
5个月前
已完结
皖公网安备34019202002308
